
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; Angiotensin converting enzyme inhibitors; ARB; Angiotensin receptor blocker; BP; Blood pressure; CCB; Calcium channel blocker; CHD; Coronary heart disease; CKD; Chronic kidney disease; CPGs; Clinical practice guidelines; CV; Cardiovascular; DHP-CCB;